Диагностика и антимикробная терапия катетер-ассоциированных инфекций кровотока

1. Mermel L, Farr B, Sheretz R et al. Guidelines for the management of
intravascular catheter-related infections. Clin Infect Dis 2001; 32:
1249–72.
2. Warren D, Zack J, Elward A et al. Nosocomial primary bloodstream
infections in intensive care unit patients in a nonteaching community
medical center: a 21-month prospective study. Clin Infect Dis 2001; 33:
1329–35.
3. Bouza E, San Juan R, Munoz P et al. A European perspective on
intravascular catheter-related infections: report on the microbiology,
workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study).
Clin Microbiol Infect 2004; 10: 838–42.
4. McGee D, Gould M. Preventing complications of central venous
catheterization. N Engl J Med 2003; 348: 1123–33.
5. Richards M, Edwards J, Culver D et al. Nosocomial infections in medical
intensive care units in the United States. Crit Care Med 1999; 27:
887–92.
6. Munoz P, Bouza E, San Juan R et al. Clinical-epidemiological characteristics
and outcome of patients with catheter-related bloodstream
infections in Europe (ESGNI-006 Study). Clin Microbiol Infect 2004; 10:
843–5.
7. Miller D, O’Grady N. Guidelines for the prevention of intravascular
catheter-related infections: recommendations relevant to interventional
radiology. J Vasc Intervent Rad 2003; 14: 133–6.
8. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related
bacteremia. Am J Resp Crit Care Med 2001; 163: 1584–90.
9. Walsh T, Rex J. All catheter-related candidemia is not the same: assessment
of the balance between the risks and benefits of removal of vascular
catheters. Clin Infect Dis 2002; 34: 600–2.
10. Lee H, Koh Y, Kim J et al. Capacity of multidrug-resistant clinical isolates
of Acinetobacter baumannii to form biofilm and adhere to epithelial
cell surfaces. Clin Microbiol Infect 2008; 14: 49–54.
11. Lai C, Wong W, Chin C et al. Central venous catheter-related
Stenotrophomonas maltophilia bacteraemia and associated relapsing
bacteraemia in haematology and oncology patients. Clin Microbiol Infect
2006; 12: 986–91.
12. Beukinga I, Rodriguez-Villalobos Y, Deplano A et al. Management of
long-term catheter-related Brevibacterium bacteraemia. Clin Microbiol
Infect 2004; 10: 465–7.
13. Safdar N, Maki D. The pathogenesis of catheter-related bloodstream
infection with noncuffed short-term central venous catheters. Inten Care
Med 2004; 30: 62–7.
14. Руководство по инфекционному контролю в стационаре. Под
ред. Р.Венцель, Т.Бревер, Ж.Бутцлер. Пер. с англ. Смоленск: МАКМАХ,
2003;с. 18–20.
15. Blot F. Diagnosis of catheter-related infections. In: Siefert H., Jansen B.,
Farr B.M., eds. Catheter-related infections. 2nd ed. New York: Marcel
Dekker; 2004; p. 37–72.
16. Gilbert DN, Doworkin RJ, Raber SR, Leggett JE. Outpatient parenteral
antimicrobial drug therapy. N Engl J Med 1997; 337: 829–38.
17. Sheretz RJ. Pathogenesis of vascular catheter-related infections. In:
Seifert H., Jansen B., Farr B.M., eds. Catheter-related infections. New York:
Marcel Dekker, 1997; 1–30.
18. Pascual A. Pathogenesis of catheter-related infections: lessons for new
designs. Clin Microbiol Infect 2002; 8: 256–64.
19. O’Grady N, Alexander M, Dellenger E et al. Gudelines for the prevention
of intravascular catheter-related infections. Clin Infect Dis 2002; 35:
1281–307.
20. Conlon RV, Humphreys H, O’Gara JP. icaR incodes a transcriptional
repressor involved in envirronmental regulation of ica operon expression
and biofilm formation in Staphylococcus epidermidis. J Bacteriol
2002; 184: 4400–8.
21. Fitzpatrick F, Humphreys H, O’Gara P. The genetics of staphylococcal
biofilm formation – will a greater understanding of pathogenesis lead to
better management of device-related infection? Clin Microbiol Infect
2005; 11: 967–73.
22. Frebourg NB, Lefebvre S, Baert S, Lemeland JF. PCR-Based assay for
discrimination between invasive and contaminating Staphylococcus
epidermidis strains. J Clin Microbiol 2000; 38: 877–80.
23. Rupp ME, Ulphani JS, Fey PD, Mack D. Characterization of Staphylococcus
epidermidis polysaccharide intercellular adhesion/hemagglutinin
in the pathogenesis of intravascular catheter-associated infection
in a rat model. Infect Immun 1999; 67: 2656–9.
24. Lyte M, Freestone P, Neal C et al. Stimulation of Staphylococcus epidermidis
growth and biofilm formation by catecholamine inotropes.
Lancet 2003; 361: 130–5.
25. Maki D. Pathogenesis, prevention and management of infections due
to intravascular devices used for infusion therapy. In: Bisno A., Waldvogel
F. eds. Infections associated with indwelling medical devices, 2nd ed.
Washington D.C.: American Socciety for Microbiology, 1994; 155–212.
26. Safdar N, Fine J, Maki D. Meta-analysis: methods for diagnosing
intravascular device-related bloodstream infection. Ann Intern Med
2005; 142: 451–66.
27. Franclin J, Gaur A, Shenep J et al. In situ diagnosis of central venous
catheter-related bloodstreem infection without peripheral blood culture.
Pediatr Infect Dis J 2004; 23: 614–8.
28. Raad I, Hanna H, Alakech B et al. Differential time to positivity: a useful
method for diagnosing catheter-related bloodstream infections. Ann
Intern Med 2004; 140: 18–25.
29. Jernigan J, Farr B. Short-course therapy of catheter-related Staphylococcus
aureus bacteremia: a meta-analysis. Ann Intern Med 1993; 119:
304–11.
30. Lecciones J, Lee J, Navarro E et al. Vascular catheter-associated
fungemia in patients with cancer: analysis of 155 episodes. Clin Infect
Dis 1992; 14: 875–83.
31. Raad I, Vartivarian S, Khan A, Bodey G. Catheter-related infections
caused by Mycobacterium fortuitum complex: 15 cases and review. Rev
Infect Dis 1991; 13: 1120–5.
32. Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal
therapy against Candida spp. in the intensive care unit. Int J Antimicrob
Agents 2000; 15: 83–90.
33. Cunha BA. Methicillin-resistant Staphylococcus aureus: clinical manifestations
and antimicrobial therapy. Clin Microbiol Infect 2005; 11
(Suppl. 4): 33–42.
34. Simon A, Bode U, Beutel K. Diagnosis and treatment of catheter-related
infections in paediatric oncology: an update. Clin Microbiol Infect
2006; 12: 606–20.
35. Isiklar Zu, Droviche RO, Landon GC, Beck T. Efficacy of antibiotcs
alone for orthopaedic device related infections. Clin Orthop 1996; 332:
184–9.
36. Pascual A, Ramirez E, Perea EJ. Activity of glycopeptides in combination
with amicacin or rifampicin against S.epidermidis biofilms on plastic
catheters. Eur J Clin Microb Infect Dis 1994; 13: 515–7.
37. Seifert H, Jansen B, Widmer AF, Farr BM. Central-venous catheters. In:
Seifert H., Jansen B., Farr B.M., editors. Catheter-related infections. 2nd ed.
New York: Marcel Dekker; 2004; p. 293–315.
38. Berrington A, Gould F. Use of antibiotic kocks to treat colonized central
venous catheters. J Antimicrob Chemother 2001; 48: 597–603.
39. Droste J, Jeraj H, MacDonald A, Farrington K. Stability and in vitro efficacy
of antibiotic-heperin lock solutions potentially useful for treatment
of central venous catheter-related sepsis. J Antimicrob Chemother 2003;
51: 849–55.
40. Poole C, Carltjn D, Bimbo L, Allon M. Treatment of catheter-related
bacteraemia with an antibiotic lock protocol: effect of bacterial
pathogen. Nephrol Dial Transplant 2004; 19: 1237–44.
41. Rijnders B, Van Wijngaerden E, Vandecasteele S et al. Treatment of
long-term intravascular catheter-related bactaeremia with antibiotic
lock: randomized, placebo-controlled trial. J Antimicrob Chemother
2005; 55: 90–4.